MLAB News and Press, Mesa Laboratories Inc. From 06/21/23

LAKEWOOD, Colo., June 21, 2023 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) will issue a press release with financial results for the first quarter of fiscal year 2024 at approximately 8:00 A.M. Eastern time on Thursday, August 3, 2023. About Mesa Laboratories, Inc. Mesa is a...

2023-06-08 01:47:11 ET Summary Mesa Laboratories' FY'22 results show a decline in revenues and profitability, leading to a hold rating on the stock. Despite growth opportunities in the clinical genomics segment, the company's lack of economic earnings and expensive valuations make...

2023-05-29 04:56:42 ET Summary Cryoport continues to grow its top line, while bottom line results are improving. The picture isn't as positive as it initially appears, but progress is still very much welcomed. Even so, the firm still has problems and shares look far too pricey...

2023-05-25 08:47:39 ET Mesa Laboratories press release ( NASDAQ: MLAB ): Q1 GAAP EPS of $0.11 misses by $0.26 . Revenue of $55.59M (+10.2% Y/Y) misses by $2.46M . For further details see: Mesa Laboratories GAAP EPS of $0.11 misses by $0.26, revenue of $55...

LAKEWOOD, Colo., May 25, 2023 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacturing of life science tools and critical quality control solutions, today announced results for its fourth fiscal quarter (“4Q23”) and fiscal year (...

LAKEWOOD, Colo., March 13, 2023 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (“Mesa” or the “Company”) is a global leader in the design and manufacture of life science tools and critical quality control solutions. Mesa has monitored the situation at Silico...

LAKEWOOD, Colo., March 09, 2023 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) will issue a press release with financial results for the fourth quarter and the fiscal year ending March 31, 2023 at approximately 8:00 A.M. Eastern time on Thursday, May 25, 2023. About Mesa Labora...

Summary In Q3, Mesa Laboratories reported mixed results throughout the P&L with soft bottom-line fundamentals. FCF growth still lumpy with contraction in divisional growth. Valuations unsupportive for re-rating to the upside. Reiterate hold. For further...

Mesa Labs Releases Environmental, Social, and Governance Program Brochure PR Newswire LAKEWOOD, Colo. , Feb. 13, 2023 /PRNewswire/ -- Mesa Laboratories, Inc. (NASDAQ: MLAB, "Mesa" "we" "our" or the "Company"), a global leader in the design and manufacturing of li...

Summary Cryoport has significantly underperformed the broader market over the past several months, largely due to poor earnings and cash flows. The company has excess cash on its books, but this doesn't make it a great prospect when you consider its continued profitability issues. A...